跳至主要内容
临床试验/NL-OMON38127
NL-OMON38127已完成3 期

SYMPTOMATIC IMPROVEMENT BY PERITONEAL DIALYSIS IN PATIENTS WITH END STAGE CONGESTIVE HEART FAILURE - Peritoneal dialysis in congestive heart failure.

Martini Ziekenhuis0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with refractory congestive heart failure, class 3-4:
  • 1. Age > 18 years.
  • 2. Refractory Left Ventricular Congestive Heart Failure: LVEF < 30%.
  • 3. Diminished renal function: eGFR < 60 ml/min, as mean of the last three measurements.
  • 4. Clinically volume overloaded: dyspnoea NYHA III-IV, edema, and/or ascites
  • 5. Chronic CHF during the last 6 months despite evaluation and optimalization by a cardiologist.
  • 6. Patient is on optimal cardiologic medical therapy, which has been stable for more than 4 weeks.
  • 7. Suitable for PD.

排除标准

  • 1. Hypotension (SBP < 100 mmHg / MAP < 70 mmHg).
  • 2. Instable AP or an elevated troponine-I level > 0,4 ug/l within the last 3 months or > 1 ug/l within the last 6 months.
  • 3. Contraindications for PD (e.g. visual handicap, social).
  • 4. Liver failure.
  • 5. COPD Gold class IV.
  • 6. Malignancy with life expectancy < 2 years.
  • 7. Non compliance.
  • 8. No informed consent.
  • 9. Poor mental health.

研究者

相似试验